Toxicity and carcinogenicity of nickel compounds.
The toxicity and carcinogenicity of nickel compounds are considered in three broad categories: (1) systemic toxicology, (2) molecular toxicology, and (3) carcinogenicity. The systemic toxicity of nickel compounds is examined based upon human and animal studies. The major organs affected are discussed in three categories: (1) kidney, (2) immune system, and (3) other organs. The second area of concentration is molecular toxicology, which will include a discussion of the chemistry of nickel, its binding to small and large molecular weight ligands, and, finally, its cellular effects. The third major area involves a discussion of the carcinogenicity and genotoxicity of nickel compounds. This section focuses on mechanisms, using studies conducted in vivo and in vitro. It also includes a discussion of the assessment of the carcinogenicity of nickel compounds.
Coogan
T P
TP
Institute of Environmental Medicine, New York University Medical Center, New York.
Latta
D M
DM
Snow
E T
ET
Costa
M
M
D000818:Animals; D002273:Carcinogens; D006801:Humans; D009532:Nickel / Q000493:pharmacokinetics / Q000633:toxicity*
D002273:Carcinogens; D009532:Nickel